Pulmatrix is a clinical stage pharmaceutical company developing a broad new class of inhaled therapies that treat, prevent and help control infectious and progressive respiratory diseases.
|Primary Business Focus||Biotechnology - Pharmaceutical|
|John Hanrahan||Chief Medical Officer/SVP||email available to subscribers|
|Molly Rosano||VP Clinical Operations|
|Eva Jack||Chief Business Officer|
* Downloads will not contain Personnel E-mail addresses
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.